BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 25452304)

  • 1. The calcineurin-NFAT axis controls allograft immunity in myeloid-derived suppressor cells through reprogramming T cell differentiation.
    Wang X; Bi Y; Xue L; Liao J; Chen X; Lu Y; Zhang Z; Wang J; Liu H; Yang H; Liu G
    Mol Cell Biol; 2015 Feb; 35(3):598-609. PubMed ID: 25452304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone potentiates myeloid-derived suppressor cell function in prolonging allograft survival through nitric oxide.
    Liao J; Wang X; Bi Y; Shen B; Shao K; Yang H; Lu Y; Zhang Z; Chen X; Liu H; Wang J; Chu Y; Xue L; Wang X; Liu G
    J Leukoc Biol; 2014 Nov; 96(5):675-84. PubMed ID: 24948701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of immunosuppressive drug cyclosporine A on myeloid-derived suppressor cells in transplanted mice.
    Han C; Wu T; Na N; Zhao Y; Li W; Zhao Y
    Inflamm Res; 2016 Sep; 65(9):679-88. PubMed ID: 27147271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergism of a natural plant product, oleanolic acid with calcineurin inhibitor in prolonging islet allograft survival.
    Angaswamy N; Tiriveedhi V; Banan B; Benshoff N; Chapman W; Mohanakumar T
    Transpl Immunol; 2013 Dec; 29(1-4):64-70. PubMed ID: 24036218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor myeloid derived suppressor cells (MDSCs) prolong allogeneic cardiac graft survival through programming of recipient myeloid cells in vivo.
    Cai S; Choi JY; Borges TJ; Zhang H; Miao J; Ichimura T; Li X; Xu S; Chu P; Eskandari SK; Allos H; Alhaddad JB; Muhsin SA; Yatim K; Riella LV; Sage PT; Chandraker AK; Azzi JR
    Sci Rep; 2020 Aug; 10(1):14249. PubMed ID: 32859934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts.
    Zhang W; Liang S; Wu J; Horuzsko A
    Transplantation; 2008 Oct; 86(8):1125-34. PubMed ID: 18946352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting S1P1 receptor protects against murine immunological hepatic injury through myeloid-derived suppressor cells.
    Liu G; Bi Y; Wang R; Yang H; Zhang Y; Wang X; Liu H; Lu Y; Zhang Z; Chen W; Chu Y; Yang R
    J Immunol; 2014 Apr; 192(7):3068-79. PubMed ID: 24567529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
    Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
    J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
    Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
    Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice.
    Schmid M; Zimara N; Wege AK; Ritter U
    Eur J Immunol; 2014 Nov; 44(11):3295-306. PubMed ID: 25142017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive intestinal peptide induces CD14+HLA-DR‑/low myeloid-derived suppressor cells in gastric cancer.
    Li G; Wu K; Tao K; Lu X; Ma J; Mao Z; Li H; Shi L; Li J; Niu Y; Xiang F; Wang G
    Mol Med Rep; 2015 Jul; 12(1):760-8. PubMed ID: 25695487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preemptive donor apoptotic cell infusions induce IFN-γ-producing myeloid-derived suppressor cells for cardiac allograft protection.
    Bryant J; Lerret NM; Wang JJ; Kang HK; Tasch J; Zhang Z; Luo X
    J Immunol; 2014 Jun; 192(12):6092-101. PubMed ID: 24808363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of a synthetic peptide inhibitor of nuclear factor of activated T cells as antirestenotic agent.
    Yu H; Sliedregt-Bol K; Overkleeft H; van der Marel GA; van Berkel TJ; Biessen EA
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1531-7. PubMed ID: 16675727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression.
    Beutelspacher SC; Pillai R; Watson MP; Tan PH; Tsang J; McClure MO; George AJ; Larkin DF
    Eur J Immunol; 2006 Mar; 36(3):690-700. PubMed ID: 16482510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD11b(+) cells in donor-specific transfusion prolonged allogenic skin graft survival through indoleamine 2,3-dioxygenase.
    Ikemoto T; Takita M; Levy MF; Shimada M; Naziruddin B
    Cell Immunol; 2013; 283(1-2):81-90. PubMed ID: 23933136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene delivery of indoleamine 2,3-dioxygenase prolongs cardiac allograft survival by shaping the types of T-cell responses.
    Yu G; Dai H; Chen J; Duan L; Gong M; Liu L; Xiong P; Wang CY; Fang M; Gong F
    J Gene Med; 2008 Jul; 10(7):754-61. PubMed ID: 18452241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury.
    Zhang C; Wang S; Li J; Zhang W; Zheng L; Yang C; Zhu T; Rong R
    Cell Death Dis; 2017 Mar; 8(3):e2695. PubMed ID: 28333137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad3-deficient CD11b(+)Gr1(+) myeloid-derived suppressor cells prevent allograft rejection via the nitric oxide pathway.
    Wu T; Sun C; Chen Z; Zhen Y; Peng J; Qi Z; Yang X; Zhao Y
    J Immunol; 2012 Nov; 189(10):4989-5000. PubMed ID: 23045614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gr-1intCD11b+ myeloid-derived suppressor cells accumulate in corneal allograft and improve corneal allograft survival.
    Choi W; Ji YW; Ham HY; Yeo A; Noh H; Jin SE; Song JS; Kim HC; Kim EK; Lee HK
    J Leukoc Biol; 2016 Dec; 100(6):1453-1463. PubMed ID: 27370015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival.
    Turnquist HR; Zhao Z; Rosborough BR; Liu Q; Castellaneta A; Isse K; Wang Z; Lang M; Stolz DB; Zheng XX; Demetris AJ; Liew FY; Wood KJ; Thomson AW
    J Immunol; 2011 Nov; 187(9):4598-610. PubMed ID: 21949025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.